NewLink Genetics (NLNK) Says Merck (MRK) Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920 to FDA
Tweet Send to a Friend
NewLink Genetics Corporation (NASDAQ: NLNK) reported today that Merck has begun the submission of a rolling Biologics License Application (BLA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
